Cargando…
Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes
BACKGROUND: Colorectal cancer (CRC) remains a leading cause of death worldwide. Utilizing cisplatin in CRC is correlated with severe adverse effects and drug-resistance. Combined anticancer drug-treatment, along with, their enhanced delivery, can effectively kill cancer through multiple pathways. Na...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094476/ https://www.ncbi.nlm.nih.gov/pubmed/30111296 http://dx.doi.org/10.1186/s12885-018-4727-5 |